Robotic Sewing Systems Could Reshape Global Apparel Supply Chains CJ Expands KCulture Push From Bibigo Dumplings to Premium Korean Spirits at the Byron Nelson Positive Early Reception for The Mandalorian and Grogu Could Bolster Disneys Star Wars Franchise Value Snowflake Shares Surge on Enterprise AI Demand and AWS Collaboration Morgan Stanley Adjusts Palo Alto Networks Stock Price Target Amid Demand Trends Critical Medicines Act Poised to Reshape Pharmaceutical Manufacturing and Supply Resilience in Europe ASTC Q1 2024 Earnings Continued Losses Amid Strategic Repositioning BrightView Holdings BV Q1 2026 Earnings EPS Misses Estimates Amid Strategic Execution VMD Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges NXE Q1 2026 Earnings Heavy Losses No Revenue but Stock Edges Higher SEER Q1 2026 Earnings Narrowly Beats EPS Estimates as Company Maintains Cost Discipline CNP Q1 2026 Earnings Narrow EPS Miss Modest Stock Uptick Amid Utility Stability Alignment Healthcare ALHC Holds Steady Near Key Levels as Trading Volume Normalizes ADAMI Senior Notes Slip Slightly as FixedIncome Market Faces Mixed Signals Eli Lilly LLY Rises 224 as Stock Flirts with Key Resistance at 1118 Nuveen CA Municipal Value Fund NCA Edges Higher Amid Steady Municipal Bond Demand Select Medical Holdings SEM Holds Steady Near Key Support After Modest Uptick US Stocks Open Higher as AI Momentum and Mideast Truce Hopes Lift Sentiment SSB Q1 2026 Earnings Earnings Per Share Beats Estimates Stock Edges Higher The Marzetti Company MZTI Gains Momentum Breaking Above Key Support Levels BUD Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Cost Discipline McGraw Hill Inc MH Q1 2026 Earnings Strong EPS Surprise of 18455 Despite Stock Decline MDGL Q1 2026 Earnings Narrowed Loss Beats Expectations as Rezdiffra Launch Progresses INCY Q1 2026 Earnings Strong EPS Beat of 2943 Surprises Analysts Tyra Biosciences Inc TYRA Q1 2026 Earnings WiderThanExpected Loss as Clinical Pipeline Progress Continues Purple Biotech Ltd PPBT Q1 2025 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances LTRN Q1 2026 Earnings Narrowed Loss Per Share Beats Estimates as Pipeline Progress Continues